ZURA Zura Bio Limited - Class A Ordinary shares
$4.16
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$1–$7
49% of range
Analyst Rating
BUY
14 analysts
Price Target
$16
+277% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
ZURA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.16
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $7
ZURA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ZURA
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ZURA
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ZURA
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ZURA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ZURA
Peer Median
ZURA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 6 42.9%
- Buy 7 50.0%
- Hold 1 7.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-05-14
Median
$15.00
← Below all targets
$4.16
Low
$11.00
High
$26.00
Median target
$15.00
+260.6%
Mean target
$15.67
+276.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.05%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.22 | $-0.18 | -0.04% |
| Dec. 31, 2025 | $-0.49 | $-0.20 | -0.29% |
| Sept. 30, 2025 | $-0.21 | $-0.19 | -0.02% |
| June 30, 2025 | $-0.17 | $-0.19 | 0.02% |
| March 31, 2025 | $-0.19 | $-0.16 | -0.03% |
| Dec. 31, 2024 | $-0.10 | $-0.16 | 0.06% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ZURA | — | — | — | — | — | — |
| MNPR | — | — | — | — | — | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
| BNTC | $307M | -11.1 | 2.7% | — | -43.8% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| GLSI | $148M | -9.3 | — | — | -420.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| R&D Expense | $15M | $10M | |
| SG&A Expense | $11M | $9M | |
| Operating Expenses | $25M | $19M | |
| Operating Income | $-25M | $-19M | |
| Interest Income | $1M | $2M | |
| Other Non-op | $-43.0K | $-5.0K | |
| Pretax Income | $-24M | $-17M | |
| Income Tax | $0 | $0 | |
| Net Income | $-24M | $-17M | |
| EPS (Basic) | $-0.22 | $-0.19 | |
| EPS (Diluted) | $-0.22 | $-0.19 | |
| Shares (Basic) | 112,222,789 | 92,964,048 | |
| Shares (Diluted) | 112,222,789 | 92,964,048 | |
| EBITDA | $-25M | · |
Balance Sheet 15
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $226M | · | |
| Prepaid Expense | $1M | · | |
| Current Assets | $227M | · | |
| PP&E (Net) | $125.0K | · | |
| Other Non-current Assets | $2M | · | |
| Total Assets | $229M | · | |
| Accounts Payable | $2M | · | |
| Current Liabilities | $12M | · | |
| Total Liabilities | $12M | · | |
| Common Stock | $9.0K | · | |
| Paid-in Capital | $466M | · | |
| Retained Earnings | $-249M | · | |
| Stockholders' Equity | $217M | · | |
| Liabilities + Equity | $229M | · | |
| Shares Outstanding | 94,880,710 | · |
Cash Flow 9
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $16.0K | $9.0K | |
| Stock-based Comp | $5M | $4M | |
| Other Non-cash | $276.0K | · | |
| Operating Cash Flow | $-19M | $-11M | |
| CapEx | $13.0K | $49.0K | |
| Investing Cash Flow | $-13.0K | $-49.0K | |
| Financing Cash Flow | $135M | $5M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-19M | · |
Profitability 3
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| ROA | -12.1% | · | |
| ROE | -13.6% | · | |
| ROIC | -11.8% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 19.3 | · | |
| Quick Ratio | 19.2 | · |
Valuation (TTM) 8
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Net Income TTM | $-76M | · | |
| Market Cap | $565M | · | |
| P/E | -7.5 | · | |
| P/B | 2.6 | · | |
| P / Tangible Book | 2.6 | · | |
| P / Cash Flow | -29.8 | · | |
| P / FCF | -29.8 | · | |
| Earnings Yield | -13.3% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.